Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism
暂无分享,去创建一个
Rachel L. Mistur | S. de Santi | M. D. de Leon | L. Mosconi | W. Tsui | E. Pirraglia | M. Brys | Lidia Glodzik | Remigiusz Switalski
[1] M. D. de Leon,et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[3] P. Whitehouse,et al. Mild cognitive impairment , 2006, Lancet.
[4] A. Drzezga,et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] A. Convit,et al. Reduced hippocampal metabolism in MCI and AD , 2005, Neurology.
[6] D. Marin,et al. Variability of familial risk of Alzheimer disease across the late life span. , 2005, Archives of general psychiatry.
[7] L. Mosconi,et al. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[8] D. Perani,et al. MCI conversion to dementia and the APOE genotype , 2004, Neurology.
[9] R. Green,et al. Estimating risk curves for first-degree relatives of patients with Alzheimer’s disease: The REVEAL study , 2004, Genetics in Medicine.
[10] G. Alexander,et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Drzezga,et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[12] J. Baron,et al. Mild cognitive impairment , 2003, Neurology.
[13] D. Fallin,et al. Evidence for parent of origin effect in late-onset Alzheimer disease. , 2002, American journal of medical genetics.
[14] R. Green,et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. , 2002, JAMA.
[15] Lars Bertram,et al. New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.
[16] M. Bobinski,et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] F Gonzalez-Lima,et al. Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration , 2001, The Journal of Neuroscience.
[18] G. Alexander,et al. Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Nunomura,et al. Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.
[21] R. Swerdlow,et al. Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines , 2000, Experimental Neurology.
[22] K. Davis,et al. Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease. , 1999, American journal of medical genetics.
[23] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[24] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[25] R. Davis,et al. Cybrids in Alzheimer's disease: A cellular model of the disease? , 1997, Neurology.
[26] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[27] John X. Morris,et al. Increased risk of dementia in mothers of Alzheimer's disease cases , 1996, Neurology.
[28] Streichenwein Sm,et al. Am J Psychiatry , 1996 .
[29] R. Frackowiak,et al. Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree. , 1995, Brain : a journal of neurology.
[30] M. Beal,et al. Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease , 1994, Journal of neurochemistry.
[31] B. Hyman,et al. Functional Alterations in Alzheimer's Disease: Selective Loss of Mitochondrial-encoded Cytochrome Oxidase mRNA in the Hippocampal Formation , 1994, Journal of neuropathology and experimental neurology.
[32] L. Thal,et al. A validation study of the Dementia Questionnaire. , 1994, Archives of neurology.
[33] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[34] M. Leon,et al. Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies. , 1986, AJNR. American journal of neuroradiology.
[35] C. D. Arnett,et al. Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] V. Hachinski,et al. A NEW DEFINITION OF ALZHEIMER'S DISEASE: A HIPPOCAMPAL DEMENTIA , 1985, The Lancet.
[37] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[38] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[39] B. Reisberg,et al. The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.
[40] R. Maclennan,et al. DIETARY FIBRE, TRANSIT-TIME, FÆCAL BACTERIA, STEROIDS, AND COLON CANCER IN TWO SCANDINAVIAN POPULATIONS Report from the International Agency for Research on Cancer Intestinal Microecology Group , 1977, The Lancet.
[41] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[42] J. Lucas,et al. The construction of viable nuclear-cytoplasmic hybrid cells by nuclear transplantation , 1976, Cell.
[43] N. Lassen,et al. Multi-infarct dementia. A cause of mental deterioration in the elderly. , 1974, Lancet.
[44] Sabrina S Wilson. Radiology , 1938, Glasgow Medical Journal.
[45] Manjit,et al. Neurology , 1912, NeuroImage.
[46] J. Winn,et al. Brain , 1878, The Lancet.
[47] Karl J. Friston,et al. A unified statistical approach for determining significant signals in images of cerebral activation , 1996, Human brain mapping.
[48] J. E. Davis,et al. Crossing cultural divides: moral conflict and the Cairo population conference. , 1995, Virginia review of sociology.
[49] G. Desplanques. Measuring fertility differentials from census information alone. , 1994, Population. English selection.
[50] G WhittakerP,et al. 共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値 , 1980 .